Daunorubicin
Generic name: Pronounced as (daw'' noe roo' bi sin)
Medical Content Reviewed By HelloPharmacist Staff
Last Revised - 12/15/2011
On this page
- Why is this medication prescribed?
- How should this medicine be used?
- Other uses for this medicine
- What special precautions should I follow?
- What special dietary instructions should I follow?
- What side effects can this medication cause?
- What should I do in case of OVERDOSE?
- What OTHER INFORMATION should I know?
- Other names
- Drug interactions
IMPORTANT WARNING
Daunorubicin injection must be given in a hospital or medical facility under the supervision of a doctor who is experienced in giving chemotherapy medications for cancer.
Daunorubicin may cause serious or life-threatening heart problems at any time during your treatment or months to years after your treatment has ended. Your doctor will order tests before and during your treatment to see if your heart is working well enough for you to safely receive daunorubicin. These tests may include an electrocardiogram (ECG; test that records the electrical activity of the heart) and an echocardiogram (test that uses sound waves to measure your heart's ability to pump blood). Your doctor may tell you that you should not receive this medication if the tests show your heart's ability to pump blood has decreased. Tell your doctor if you have or have ever had any type of heart disease or radiation (x-ray) therapy to the chest area. Tell your doctor and pharmacist if you are taking or have ever received certain cancer chemotherapy medications such as doxorubicin (Doxil), epirubicin (Ellence), idarubicin (Idamycin), or mitoxantrone (Novantrone), cyclophosphamide (Cytoxan), or trastuzumab (Herceptin). If you experience any of the following symptoms, call your doctor immediately: shortness of breath; difficulty breathing; swelling of the hands, feet, ankles or lower legs; or fast, irregular, or pounding heartbeat.
Daunorubicin can cause a severe decrease in the number of blood cells in your bone marrow. This may cause certain symptoms and may increase the risk that you will develop a serious infection or bleeding. If you experience any of the following symptoms, call your doctor immediately: fever, sore throat, ongoing cough and congestion, or other signs of infection; unusual bleeding or bruising.
Tell your doctor if you have or have ever had kidney or liver disease. Your doctor may need to adjust your dose if you have kidney or liver disease.
Keep all appointments with your doctor and the laboratory. Your doctor will order certain tests to check your body's response to daunorubicin.
Why is this medication prescribed?
Daunorubicin is used with other chemotherapy drugs to treat a certain type of acute myeloid leukemia (AML; a type of cancer of the white blood cells). Daunorubicin is also used with other chemotherapy drugs to treat a certain type of acute lymphocytic leukemia (ALL; a type of cancer of the white blood cells). Daunorubicin is in a class of medications called anthracyclines. It works by slowing or stopping the growth of cancer cells in your body.
How should this medicine be used?
Daunorubicin comes as a solution (liquid) or as a powder to be mixed with liquid to be injected intravenously (into a vein) by a doctor or nurse in a medical facility along with other chemotherapy medications. When daunorubicin is used to treat AML, it is usually injected once a day on certain days of your treatment period. When daunorubicin is used to treat ALL, it is usually injected once a week. The length of treatment depends on the types of drugs you are taking, how well your body responds to them, and the type of cancer you have.
Ask your pharmacist or doctor for a copy of the manufacturer's information for the patient.
Other uses for this medicine
This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.
What special precautions should I follow?
Before receiving daunorubicin injection,
-
tell your doctor and pharmacist if you are allergic to daunorubicin, any other medications, or any of the ingredients in daunorubicin injection. Ask your pharmacist for a list of the ingredients.
-
tell your doctor and pharmacist what other prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Be sure to mention the medications listed in the IMPORTANT WARNING section and any of the following: azathioprine (Imuran), cyclosporine (Neoral, Sandimmune), methotrexate (Rheumatrex, Trexall), sirolimus (Rapamune), and tacrolimus (Prograf). Your doctor may need to change the doses of your medications or monitor you carefully for side effects. Other medications may also interact with daunorubicin, so be sure to tell your doctor about all the medications you are taking, even those that do not appear on this list.
-
tell your doctor if you have or have ever had any medical condition.
-
tell your doctor if you are pregnant, plan to become pregnant, or are breast-feeding. You should not become pregnant while you are receiving daunorubicin injection. If you become pregnant while receiving daunorubicin, call your doctor. Daunorubicin may harm the fetus.
What special dietary instructions should I follow?
Unless your doctor tells you otherwise, continue your normal diet.
What side effects can this medication cause?
-
Daunorubicin may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:
-
nausea
-
vomiting
-
sores in the mouth and throat
-
diarrhea
-
stomach pain
-
hair loss
-
red urine
-
-
Some side effects can be serious. If you experience any of these symptoms or those listed in the IMPORTANT WARNING section, call your doctor immediately:
-
redness, pain, swelling, or burning at the site where the injection was given
-
rash
-
hives
-
itching
-
difficulty breathing or swallowing
-
-
Daunorubicin may increase the risk that you will develop other cancers. Talk to your doctor about the risks of taking this medication.
-
Daunorubicin may cause other side effects. Call your doctor if you have any unusual problems while taking this medication.
-
If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).
What should I do in case of OVERDOSE?
In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.
What OTHER INFORMATION should I know?
It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.
Drug interactions
Drug | Interaction |
---|---|
Repaglinide | Repaglinide Daunorubicin may decrease the excretion rate of Repaglinide which could result in a higher serum level. |
Leflunomide | Leflunomide The risk or severity of adverse effects can be increased when Daunorubicin is combined with Leflunomide. |
Nevirapine | Nevirapine The metabolism of Nevirapine can be increased when combined with Daunorubicin. |
Atorvastatin | Atorvastatin The metabolism of Atorvastatin can be decreased when combined with Daunorubicin. |
Aminophylline | Aminophylline The metabolism of Aminophylline can be decreased when combined with Daunorubicin. |
Anagrelide | Anagrelide The risk or severity of bleeding can be increased when Anagrelide is combined with Daunorubicin. |
Cilostazol | Cilostazol The metabolism of Cilostazol can be decreased when combined with Daunorubicin. |
Clopidogrel | Clopidogrel The metabolism of Clopidogrel can be increased when combined with Daunorubicin. |
Erythromycin and Sulfisoxazole | Erythromycin and Sulfisoxazole Erythromycin may decrease the excretion rate of Daunorubicin which could result in a higher serum level. |
Fenofibrate | Fenofibrate Daunorubicin may decrease the excretion rate of Fenofibrate which could result in a higher serum level. |
Mycophenolate | Mycophenolate The risk or severity of adverse effects can be increased when Daunorubicin is combined with Mycophenolic acid. |
Prednisone | Prednisone The risk or severity of adverse effects can be increased when Prednisone is combined with Daunorubicin. |
Reserpine | Reserpine Reserpine may decrease the excretion rate of Daunorubicin which could result in a higher serum level. |
Tacrolimus | Tacrolimus The serum concentration of Tacrolimus can be increased when it is combined with Daunorubicin. |
Triamcinolone | Triamcinolone The risk or severity of adverse effects can be increased when Triamcinolone is combined with Daunorubicin. |
Interferon Beta-1b Injection | Interferon Beta-1b Injection The risk or severity of adverse effects can be increased when Interferon beta-1b is combined with Daunorubicin. |
Interferon Gamma-1b Injection | Interferon Gamma-1b Injection The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Daunorubicin. |
Meperidine Injection | Meperidine Injection The metabolism of Meperidine can be decreased when combined with Daunorubicin. |
Methylprednisolone Injection | Methylprednisolone Injection The risk or severity of adverse effects can be increased when Daunorubicin is combined with Methylprednisolone. |
Metronidazole Injection | Metronidazole Injection The metabolism of Metronidazole can be increased when combined with Daunorubicin. |
Zidovudine Injection | Zidovudine Injection The risk or severity of adverse effects can be increased when Zidovudine is combined with Daunorubicin. |
Cyclosporine | Cyclosporine Daunorubicin may increase the immunosuppressive activities of Cyclosporine. |
Ondansetron | Ondansetron The metabolism of Ondansetron can be increased when combined with Daunorubicin. |
Enoxaparin Injection | Enoxaparin Injection The risk or severity of bleeding can be increased when Enoxaparin is combined with Daunorubicin. |
Dofetilide | Dofetilide The metabolism of Dofetilide can be decreased when combined with Daunorubicin. |
Hydroxychloroquine | Hydroxychloroquine The risk or severity of adverse effects can be increased when Daunorubicin is combined with Hydroxychloroquine. |
Pantoprazole | Pantoprazole Pantoprazole may decrease the excretion rate of Daunorubicin which could result in a higher serum level. |
Telmisartan | Telmisartan Telmisartan may decrease the excretion rate of Daunorubicin which could result in a higher serum level. |
Temozolomide | Temozolomide The risk or severity of adverse effects can be increased when Daunorubicin is combined with Temozolomide. |
Zaleplon | Zaleplon The metabolism of Zaleplon can be increased when combined with Daunorubicin. |
Anakinra | Anakinra The risk or severity of adverse effects can be increased when Anakinra is combined with Daunorubicin. |
Linezolid | Linezolid The risk or severity of adverse effects can be increased when Linezolid is combined with Daunorubicin. |
Pentosan Polysulfate | Pentosan Polysulfate The risk or severity of bleeding can be increased when Pentosan polysulfate is combined with Daunorubicin. |
Etanercept Injection | Etanercept Injection The risk or severity of adverse effects can be increased when Etanercept is combined with Daunorubicin. |
Tenofovir | Tenofovir The metabolism of Tenofovir can be decreased when combined with Daunorubicin. |
Sirolimus | Sirolimus The metabolism of Sirolimus can be decreased when combined with Daunorubicin. |
Dutasteride | Dutasteride The metabolism of Dutasteride can be increased when combined with Daunorubicin. |
Epirubicin | Epirubicin The risk or severity of adverse effects can be increased when Epirubicin is combined with Daunorubicin. |
Eplerenone | Eplerenone The metabolism of Eplerenone can be increased when combined with Daunorubicin. |
Olmesartan | Olmesartan Olmesartan may decrease the excretion rate of Daunorubicin which could result in a higher serum level. |
Zonisamide | Zonisamide The metabolism of Zonisamide can be increased when combined with Daunorubicin. |
Adalimumab Injection | Adalimumab Injection The risk or severity of adverse effects can be increased when Adalimumab is combined with Daunorubicin. |
Aripiprazole | Aripiprazole The metabolism of Aripiprazole can be decreased when combined with Daunorubicin. |
Ezetimibe | Ezetimibe Daunorubicin may decrease the excretion rate of Ezetimibe which could result in a higher serum level. |
Glatiramer Injection | Glatiramer Injection The risk or severity of adverse effects can be increased when Daunorubicin is combined with Glatiramer. |
Atazanavir | Atazanavir Daunorubicin may decrease the excretion rate of Atazanavir which could result in a higher serum level. |
Rosuvastatin | Rosuvastatin Daunorubicin may decrease the excretion rate of Rosuvastatin which could result in a higher serum level. |
Vardenafil | Vardenafil The metabolism of Vardenafil can be decreased when combined with Daunorubicin. |
Alfuzosin | Alfuzosin The metabolism of Alfuzosin can be decreased when combined with Daunorubicin. |
Aprepitant | Aprepitant The metabolism of Aprepitant can be increased when combined with Daunorubicin. |
Tadalafil | Tadalafil The metabolism of Tadalafil can be increased when combined with Daunorubicin. |
Progesterone | Progesterone Progesterone may decrease the excretion rate of Daunorubicin which could result in a higher serum level. |
Apomorphine Injection | Apomorphine Injection The metabolism of Apomorphine can be increased when combined with Daunorubicin. |
Darbepoetin Alfa Injection | Darbepoetin Alfa Injection The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Daunorubicin. |
Infliximab Injection | Infliximab Injection The risk or severity of adverse effects can be increased when Infliximab is combined with Daunorubicin. |
Duloxetine | Duloxetine The metabolism of Duloxetine can be decreased when combined with Daunorubicin. |
Norethindrone | Norethindrone The metabolism of Norethisterone can be decreased when combined with Daunorubicin. |
Tinidazole | Tinidazole Daunorubicin may decrease the excretion rate of Tinidazole which could result in a higher serum level. |
Bosentan | Bosentan Bosentan may decrease the excretion rate of Daunorubicin which could result in a higher serum level. |
Natalizumab Injection | Natalizumab Injection The risk or severity of adverse effects can be increased when Daunorubicin is combined with Natalizumab. |
Erlotinib | Erlotinib The metabolism of Daunorubicin can be decreased when combined with Erlotinib. |
Eszopiclone | Eszopiclone The metabolism of Eszopiclone can be decreased when combined with Daunorubicin. |
Palifermin | Palifermin The therapeutic efficacy of Palifermin can be decreased when used in combination with Daunorubicin. |
Peginterferon Alfa-2a Injection | Peginterferon Alfa-2a Injection The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Daunorubicin. |
Peginterferon Alfa-2b (PEG-Intron) | Peginterferon Alfa-2b (PEG-Intron) The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Daunorubicin. |
Fentanyl | Fentanyl The metabolism of Fentanyl can be decreased when combined with Daunorubicin. |
Tipranavir | Tipranavir Tipranavir may decrease the excretion rate of Daunorubicin which could result in a higher serum level. |
Ranolazine | Ranolazine Ranolazine may decrease the excretion rate of Daunorubicin which could result in a higher serum level. |
Abatacept Injection | Abatacept Injection The risk or severity of adverse effects can be increased when Daunorubicin is combined with Abatacept. |
Imatinib | Imatinib The risk or severity of adverse effects can be increased when Imatinib is combined with Daunorubicin. |
Bevacizumab Injection | Bevacizumab Injection The risk or severity of adverse effects can be increased when Bevacizumab is combined with Daunorubicin. |
Gefitinib | Gefitinib Gefitinib may decrease the excretion rate of Daunorubicin which could result in a higher serum level. |
Paliperidone | Paliperidone The metabolism of Paliperidone can be increased when combined with Daunorubicin. |
Bortezomib | Bortezomib The metabolism of Daunorubicin can be decreased when combined with Bortezomib. |
Clofarabine Injection | Clofarabine Injection The risk or severity of adverse effects can be increased when Clofarabine is combined with Daunorubicin. |
Hepatitis B Vaccine | Hepatitis B Vaccine The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Daunorubicin. |
Influenza Vaccine, Inactivated or Recombinant | Influenza Vaccine, Inactivated or Recombinant The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Daunorubicin. |
Influenza Vaccine, Live Intranasal | Influenza Vaccine, Live Intranasal The risk or severity of infection can be increased when Typhoid Vaccine Live is combined with Daunorubicin. |
Live Shingles (Zoster) Vaccine (ZVL) | Live Shingles (Zoster) Vaccine (ZVL) The risk or severity of infection can be increased when Varicella Zoster Vaccine (Live/attenuated) is combined with Daunorubicin. |
Oxaliplatin Injection | Oxaliplatin Injection The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Daunorubicin. |
Rituximab Injection | Rituximab Injection The risk or severity of adverse effects can be increased when Rituximab is combined with Daunorubicin. |
Pemetrexed Injection | Pemetrexed Injection The risk or severity of adverse effects can be increased when Pemetrexed is combined with Daunorubicin. |
Retapamulin | Retapamulin The metabolism of Retapamulin can be decreased when combined with Daunorubicin. |
Vorinostat | Vorinostat The risk or severity of adverse effects can be increased when Daunorubicin is combined with Vorinostat. |
Sorafenib | Sorafenib The metabolism of Daunorubicin can be decreased when combined with Sorafenib. |
Sunitinib | Sunitinib The metabolism of Sunitinib can be decreased when combined with Daunorubicin. |
Dronabinol | Dronabinol Dronabinol may decrease the excretion rate of Daunorubicin which could result in a higher serum level. |
Lapatinib | Lapatinib The metabolism of Lapatinib can be increased when combined with Daunorubicin. |
Dasatinib | Dasatinib The metabolism of Dasatinib can be decreased when combined with Daunorubicin. |
Azacitidine Injection | Azacitidine Injection The risk or severity of adverse effects can be increased when Daunorubicin is combined with Azacitidine. |
Temsirolimus | Temsirolimus The metabolism of Temsirolimus can be decreased when combined with Daunorubicin. |
Nelarabine Injection | Nelarabine Injection The risk or severity of adverse effects can be increased when Daunorubicin is combined with Nelarabine. |
Lenalidomide | Lenalidomide The risk or severity of adverse effects can be increased when Lenalidomide is combined with Daunorubicin. |
Nilotinib | Nilotinib The metabolism of Nilotinib can be decreased when combined with Daunorubicin. |
Bexarotene | Bexarotene The risk or severity of adverse effects can be increased when Bexarotene is combined with Daunorubicin. |
Budesonide | Budesonide The risk or severity of adverse effects can be increased when Daunorubicin is combined with Budesonide. |
Chloramphenicol Injection | Chloramphenicol Injection The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Daunorubicin. |
Decitabine Injection | Decitabine Injection The risk or severity of adverse effects can be increased when Daunorubicin is combined with Decitabine. |
Arsenic Trioxide Injection | Arsenic Trioxide Injection The risk or severity of adverse effects can be increased when Daunorubicin is combined with Arsenic trioxide. |
Mitoxantrone Injection | Mitoxantrone Injection The risk or severity of adverse effects can be increased when Daunorubicin is combined with Mitoxantrone. |
Tretinoin | Tretinoin The risk or severity of adverse effects can be increased when Daunorubicin is combined with Tretinoin. |
Bendamustine Injection | Bendamustine Injection The risk or severity of adverse effects can be increased when Daunorubicin is combined with Bendamustine. |
Certolizumab Injection | Certolizumab Injection The risk or severity of adverse effects can be increased when Daunorubicin is combined with Certolizumab pegol. |
Ixabepilone Injection | Ixabepilone Injection The metabolism of Ixabepilone can be decreased when combined with Daunorubicin. |
Irinotecan Injection | Irinotecan Injection The metabolism of Irinotecan can be decreased when combined with Daunorubicin. |
Estramustine | Estramustine The risk or severity of adverse effects can be increased when Daunorubicin is combined with Estramustine. |
Praziquantel | Praziquantel The metabolism of Praziquantel can be increased when combined with Daunorubicin. |
Alemtuzumab Injection (Chronic Lymphocytic Leukemia) | Alemtuzumab Injection (Chronic Lymphocytic Leukemia) The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Daunorubicin. |
Rufinamide | Rufinamide The metabolism of Rufinamide can be decreased when combined with Daunorubicin. |
Midazolam | Midazolam The serum concentration of Midazolam can be increased when it is combined with Daunorubicin. |
Dexrazoxane Injection | Dexrazoxane Injection The risk or severity of adverse effects can be increased when Dexrazoxane is combined with Daunorubicin. |
Eltrombopag | Eltrombopag Eltrombopag may decrease the excretion rate of Daunorubicin which could result in a higher serum level. |
Ibritumomab Injection | Ibritumomab Injection The risk or severity of adverse effects can be increased when Ibritumomab tiuxetan is combined with Daunorubicin. |
Iloperidone | Iloperidone The metabolism of Iloperidone can be decreased when combined with Daunorubicin. |
Prasugrel | Prasugrel The risk or severity of bleeding can be increased when Prasugrel is combined with Daunorubicin. |
Lacosamide | Lacosamide The metabolism of Lacosamide can be decreased when combined with Daunorubicin. |
Everolimus | Everolimus The metabolism of Everolimus can be decreased when combined with Daunorubicin. |
Tolvaptan (low blood sodium) | Tolvaptan (low blood sodium) The metabolism of Tolvaptan can be decreased when combined with Daunorubicin. |
Dronedarone | Dronedarone The metabolism of Dronedarone can be decreased when combined with Daunorubicin. |
Pralatrexate Injection | Pralatrexate Injection The risk or severity of adverse effects can be increased when Daunorubicin is combined with Pralatrexate. |
Saxagliptin | Saxagliptin The metabolism of Saxagliptin can be increased when combined with Daunorubicin. |
Romidepsin Injection | Romidepsin Injection The metabolism of Romidepsin can be decreased when combined with Daunorubicin. |
Topotecan | Topotecan The risk or severity of adverse effects can be increased when Daunorubicin is combined with Topotecan. |
Golimumab Injection | Golimumab Injection The risk or severity of adverse effects can be increased when Daunorubicin is combined with Golimumab. |
Pazopanib | Pazopanib The metabolism of Pazopanib can be decreased when combined with Daunorubicin. |
Pitavastatin | Pitavastatin Daunorubicin may decrease the excretion rate of Pitavastatin which could result in a higher serum level. |
Albendazole | Albendazole The metabolism of Albendazole can be decreased when combined with Daunorubicin. |
Levonorgestrel | Levonorgestrel The metabolism of Levonorgestrel can be increased when combined with Daunorubicin. |
Denosumab Injection | Denosumab Injection The risk or severity of adverse effects can be increased when Denosumab is combined with Daunorubicin. |
Dabigatran | Dabigatran The risk or severity of bleeding can be increased when Dabigatran is combined with Daunorubicin. |
Tocilizumab Injection | Tocilizumab Injection The risk or severity of adverse effects can be increased when Daunorubicin is combined with Tocilizumab. |
Fingolimod | Fingolimod Daunorubicin may increase the immunosuppressive activities of Fingolimod. |
Eribulin Injection | Eribulin Injection The risk or severity of adverse effects can be increased when Daunorubicin is combined with Eribulin. |
Cabazitaxel Injection | Cabazitaxel Injection The metabolism of Cabazitaxel can be decreased when combined with Daunorubicin. |
Denileukin Diftitox Injection | Denileukin Diftitox Injection The risk or severity of adverse effects can be increased when Aldesleukin is combined with Daunorubicin. |
Sipuleucel-T Injection | Sipuleucel-T Injection The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Daunorubicin. |
Belimumab Injection | Belimumab Injection The risk or severity of adverse effects can be increased when Daunorubicin is combined with Belimumab. |
Busulfan Injection | Busulfan Injection The metabolism of Busulfan can be decreased when combined with Daunorubicin. |
Roflumilast | Roflumilast Roflumilast may increase the immunosuppressive activities of Daunorubicin. |
Linagliptin | Linagliptin The metabolism of Linagliptin can be decreased when combined with Daunorubicin. |
Rilpivirine | Rilpivirine Rilpivirine may decrease the excretion rate of Daunorubicin which could result in a higher serum level. |
Telaprevir | Telaprevir Glecaprevir may decrease the excretion rate of Daunorubicin which could result in a higher serum level. |
Cyclophosphamide Injection | Cyclophosphamide Injection The metabolism of Daunorubicin can be decreased when combined with Cyclophosphamide. |
Rivaroxaban | Rivaroxaban The metabolism of Rivaroxaban can be increased when combined with Daunorubicin. |
Ticagrelor | Ticagrelor The risk or severity of bleeding can be increased when Ticagrelor is combined with Daunorubicin. |
Brentuximab Vedotin Injection | Brentuximab Vedotin Injection The metabolism of Brentuximab vedotin can be decreased when combined with Daunorubicin. |
Ruxolitinib | Ruxolitinib The metabolism of Ruxolitinib can be decreased when combined with Daunorubicin. |
Vandetanib | Vandetanib The metabolism of Daunorubicin can be decreased when combined with Vandetanib. |
Vemurafenib | Vemurafenib The metabolism of Vemurafenib can be decreased when combined with Daunorubicin. |
Vismodegib | Vismodegib Vismodegib may decrease the excretion rate of Daunorubicin which could result in a higher serum level. |
Belatacept Injection | Belatacept Injection The risk or severity of adverse effects can be increased when Daunorubicin is combined with Belatacept. |
Ivacaftor | Ivacaftor The metabolism of Ivacaftor can be increased when combined with Daunorubicin. |
Basiliximab Injection | Basiliximab Injection The risk or severity of adverse effects can be increased when Basiliximab is combined with Daunorubicin. |
Axitinib | Axitinib The metabolism of Axitinib can be decreased when combined with Daunorubicin. |
Crizotinib | Crizotinib The metabolism of Crizotinib can be decreased when combined with Daunorubicin. |
Melphalan Injection | Melphalan Injection The risk or severity of adverse effects can be increased when Daunorubicin is combined with Melphalan. |
Cabergoline | Cabergoline The metabolism of Daunorubicin can be decreased when combined with Cabergoline. |
Ambrisentan | Ambrisentan The metabolism of Ambrisentan can be increased when combined with Daunorubicin. |
Eculizumab Injection | Eculizumab Injection The risk or severity of adverse effects can be increased when Daunorubicin is combined with Eculizumab. |
Fondaparinux Injection | Fondaparinux Injection The risk or severity of bleeding can be increased when Fondaparinux is combined with Daunorubicin. |
Pertuzumab Injection | Pertuzumab Injection The risk or severity of cardiotoxicity can be increased when Daunorubicin is combined with Pertuzumab. |
Carfilzomib Injection | Carfilzomib Injection The risk or severity of adverse effects can be increased when Daunorubicin is combined with Carfilzomib. |
Iloprost | Iloprost The risk or severity of bleeding can be increased when Iloprost is combined with Daunorubicin. |
Enzalutamide | Enzalutamide The metabolism of Enzalutamide can be increased when combined with Daunorubicin. |
Regorafenib | Regorafenib The metabolism of Daunorubicin can be decreased when combined with Regorafenib. |
Bosutinib | Bosutinib The metabolism of Bosutinib can be decreased when combined with Daunorubicin. |
Corticotropin, Repository Injection | Corticotropin, Repository Injection The risk or severity of adverse effects can be increased when Daunorubicin is combined with Corticotropin. |
Teriflunomide | Teriflunomide The risk or severity of adverse effects can be increased when Daunorubicin is combined with Teriflunomide. |
Icosapent Ethyl | Icosapent Ethyl The risk or severity of bleeding can be increased when Icosapent ethyl is combined with Daunorubicin. |
Tofacitinib | Tofacitinib The metabolism of Tofacitinib can be decreased when combined with Daunorubicin. |
Dimethyl Fumarate | Dimethyl Fumarate The risk or severity of adverse effects can be increased when Daunorubicin is combined with Dimethyl fumarate. |
Ponatinib | Ponatinib The metabolism of Ponatinib can be decreased when combined with Daunorubicin. |
Pomalidomide | Pomalidomide The metabolism of Pomalidomide can be decreased when combined with Daunorubicin. |
Ado-trastuzumab Emtansine Injection | Ado-trastuzumab Emtansine Injection The metabolism of Trastuzumab emtansine can be decreased when combined with Daunorubicin. |
Apixaban | Apixaban The metabolism of Apixaban can be increased when combined with Daunorubicin. |
Dabrafenib | Dabrafenib The metabolism of Dabrafenib can be decreased when combined with Daunorubicin. |
Afatinib | Afatinib Afatinib may decrease the excretion rate of Daunorubicin which could result in a higher serum level. |
Vortioxetine | Vortioxetine The metabolism of Vortioxetine can be increased when combined with Daunorubicin. |
Perampanel | Perampanel The metabolism of Perampanel can be increased when combined with Daunorubicin. |
Ibrutinib | Ibrutinib The metabolism of Ibrutinib can be decreased when combined with Daunorubicin. |
Lomitapide | Lomitapide The metabolism of Lomitapide can be decreased when combined with Daunorubicin. |
Obinutuzumab Injection | Obinutuzumab Injection The risk or severity of adverse effects can be increased when Daunorubicin is combined with Obinutuzumab. |
Simeprevir | Simeprevir Simeprevir may decrease the excretion rate of Daunorubicin which could result in a higher serum level. |
Apremilast | Apremilast The risk or severity of adverse effects can be increased when Daunorubicin is combined with Apremilast. |
Ceritinib | Ceritinib The metabolism of Ceritinib can be decreased when combined with Daunorubicin. |
Siltuximab Injection | Siltuximab Injection The risk or severity of adverse effects can be increased when Daunorubicin is combined with Siltuximab. |
Vedolizumab Injection | Vedolizumab Injection The risk or severity of adverse effects can be increased when Daunorubicin is combined with Vedolizumab. |
Belinostat Injection | Belinostat Injection The risk or severity of adverse effects can be increased when Daunorubicin is combined with Belinostat. |
Idelalisib | Idelalisib The metabolism of Idelalisib can be decreased when combined with Daunorubicin. |
Testosterone Injection | Testosterone Injection The metabolism of Testosterone can be increased when combined with Daunorubicin. |
Vorapaxar | Vorapaxar The metabolism of Daunorubicin can be decreased when combined with Vorapaxar. |
Suvorexant | Suvorexant The metabolism of Suvorexant can be decreased when combined with Daunorubicin. |
Edoxaban | Edoxaban The risk or severity of bleeding can be increased when Edoxaban is combined with Daunorubicin. |
Peginterferon Beta-1a Injection | Peginterferon Beta-1a Injection The risk or severity of adverse effects can be increased when Daunorubicin is combined with Peginterferon beta-1a. |
Olaparib | Olaparib The metabolism of Olaparib can be decreased when combined with Daunorubicin. |
Blinatumomab Injection | Blinatumomab Injection The risk or severity of adverse effects can be increased when Daunorubicin is combined with Blinatumomab. |
Tasimelteon | Tasimelteon The metabolism of Tasimelteon can be decreased when combined with Daunorubicin. |
Pirfenidone | Pirfenidone The risk or severity of adverse effects can be increased when Daunorubicin is combined with Pirfenidone. |
Nintedanib | Nintedanib The metabolism of Nintedanib can be decreased when combined with Daunorubicin. |
Secukinumab Injection | Secukinumab Injection The risk or severity of adverse effects can be increased when Daunorubicin is combined with Secukinumab. |
Risperidone Injection | Risperidone Injection The metabolism of Risperidone can be increased when combined with Daunorubicin. |
Palbociclib | Palbociclib The metabolism of Palbociclib can be decreased when combined with Daunorubicin. |
Lenvatinib | Lenvatinib Lenvatinib may decrease the excretion rate of Daunorubicin which could result in a higher serum level. |
Panobinostat | Panobinostat The metabolism of Panobinostat can be decreased when combined with Daunorubicin. |
Dinutuximab Injection | Dinutuximab Injection The risk or severity of adverse effects can be increased when Daunorubicin is combined with Dinutuximab. |
Haloperidol Injection | Haloperidol Injection The serum concentration of Haloperidol can be increased when it is combined with Daunorubicin. |
Deoxycholic Acid Injection | Deoxycholic Acid Injection Deoxycholic acid may increase the excretion rate of Daunorubicin which could result in a lower serum level and potentially a reduction in efficacy. |
Sonidegib | Sonidegib The metabolism of Sonidegib can be decreased when combined with Daunorubicin. |
Rolapitant | Rolapitant Rolapitant may decrease the excretion rate of Daunorubicin which could result in a higher serum level. |
Prednisolone | Prednisolone The risk or severity of adverse effects can be increased when Daunorubicin is combined with Prednisolone. |
Daclatasvir | Daclatasvir Daclatasvir may decrease the excretion rate of Daunorubicin which could result in a higher serum level. |
Ziprasidone Injection | Ziprasidone Injection The metabolism of Ziprasidone can be decreased when combined with Daunorubicin. |
Cobimetinib | Cobimetinib The metabolism of Cobimetinib can be decreased when combined with Daunorubicin. |
Mepolizumab Injection | Mepolizumab Injection The risk or severity of adverse effects can be increased when Daunorubicin is combined with Mepolizumab. |
Trabectedin Injection | Trabectedin Injection The metabolism of Trabectedin can be decreased when combined with Daunorubicin. |
Osimertinib | Osimertinib The metabolism of Osimertinib can be decreased when combined with Daunorubicin. |
Alectinib | Alectinib The metabolism of Daunorubicin can be decreased when combined with Alectinib. |
Ixazomib | Ixazomib The metabolism of Ixazomib can be decreased when combined with Daunorubicin. |
Dexamethasone Injection | Dexamethasone Injection The risk or severity of adverse effects can be increased when Daunorubicin is combined with Dexamethasone. |
Defibrotide Injection | Defibrotide Injection The risk or severity of bleeding can be increased when Defibrotide is combined with Daunorubicin. |
Ixekizumab Injection | Ixekizumab Injection The risk or severity of adverse effects can be increased when Daunorubicin is combined with Ixekizumab. |
Venetoclax | Venetoclax The metabolism of Venetoclax can be decreased when combined with Daunorubicin. |
Cobicistat | Cobicistat Cobicistat may decrease the excretion rate of Daunorubicin which could result in a higher serum level. |
Rucaparib | Rucaparib Rucaparib may decrease the excretion rate of Daunorubicin which could result in a higher serum level. |
Ribociclib | Ribociclib The metabolism of Ribociclib can be decreased when combined with Daunorubicin. |
Brodalumab Injection | Brodalumab Injection The risk or severity of adverse effects can be increased when Daunorubicin is combined with Brodalumab. |
Brigatinib | Brigatinib The metabolism of Brigatinib can be decreased when combined with Daunorubicin. |
Deutetrabenazine | Deutetrabenazine The metabolism of Deutetrabenazine can be increased when combined with Daunorubicin. |
Valbenazine | Valbenazine The metabolism of Valbenazine can be increased when combined with Daunorubicin. |
Deflazacort | Deflazacort The risk or severity of adverse effects can be increased when Daunorubicin is combined with Deflazacort. |
Safinamide | Safinamide Safinamide may decrease the excretion rate of Daunorubicin which could result in a higher serum level. |
Ocrelizumab Injection | Ocrelizumab Injection Ocrelizumab may increase the immunosuppressive activities of Daunorubicin. |
Sarilumab Injection | Sarilumab Injection The risk or severity of adverse effects can be increased when Daunorubicin is combined with Sarilumab. |
Midostaurin | Midostaurin The metabolism of Midostaurin can be decreased when combined with Daunorubicin. |
Neratinib | Neratinib The metabolism of Neratinib can be decreased when combined with Daunorubicin. |
Guselkumab Injection | Guselkumab Injection The risk or severity of adverse effects can be increased when Daunorubicin is combined with Guselkumab. |
Enasidenib | Enasidenib The metabolism of Enasidenib can be decreased when combined with Daunorubicin. |
Aprepitant/Fosaprepitant Injection | Aprepitant/Fosaprepitant Injection The metabolism of Fosaprepitant can be decreased when combined with Daunorubicin. |
Copanlisib Injection | Copanlisib Injection The metabolism of Copanlisib can be decreased when combined with Daunorubicin. |
Abemaciclib | Abemaciclib The metabolism of Daunorubicin can be decreased when combined with Abemaciclib. |
Betrixaban | Betrixaban The risk or severity of bleeding can be increased when Betrixaban is combined with Daunorubicin. |
Acalabrutinib | Acalabrutinib The metabolism of Acalabrutinib can be decreased when combined with Daunorubicin. |
Gemtuzumab Ozogamicin Injection | Gemtuzumab Ozogamicin Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Daunorubicin. |
Letermovir | Letermovir Letermovir may decrease the excretion rate of Daunorubicin which could result in a higher serum level. |
Buprenorphine Injection | Buprenorphine Injection Buprenorphine may decrease the excretion rate of Daunorubicin which could result in a higher serum level. |
Apalutamide | Apalutamide Apalutamide may increase the excretion rate of Daunorubicin which could result in a lower serum level and potentially a reduction in efficacy. |
Penicillamine | Penicillamine The risk or severity of adverse effects can be increased when Daunorubicin is combined with Penicillamine. |
Fostamatinib | Fostamatinib Fostamatinib may decrease the excretion rate of Daunorubicin which could result in a higher serum level. |
Avatrombopag | Avatrombopag Avatrombopag may decrease the excretion rate of Daunorubicin which could result in a higher serum level. |
Baricitinib | Baricitinib The metabolism of Baricitinib can be decreased when combined with Daunorubicin. |
Eliglustat | Eliglustat The metabolism of Eliglustat can be decreased when combined with Daunorubicin. |
Ivosidenib | Ivosidenib The metabolism of Ivosidenib can be decreased when combined with Daunorubicin. |
Doravirine | Doravirine The metabolism of Doravirine can be increased when combined with Daunorubicin. |
Cannabidiol | Cannabidiol Cannabidiol may decrease the excretion rate of Daunorubicin which could result in a higher serum level. |
Dacomitinib | Dacomitinib The metabolism of Daunorubicin can be decreased when combined with Dacomitinib. |
Duvelisib | Duvelisib The metabolism of Duvelisib can be decreased when combined with Daunorubicin. |
Gilteritinib | Gilteritinib Gilteritinib may decrease the excretion rate of Daunorubicin which could result in a higher serum level. |
Glasdegib | Glasdegib Glasdegib may decrease the excretion rate of Daunorubicin which could result in a higher serum level. |
Lorlatinib | Lorlatinib The metabolism of Lorlatinib can be increased when combined with Daunorubicin. |
Methoxy Polyethylene Glycol-Epoetin Beta Injection | Methoxy Polyethylene Glycol-Epoetin Beta Injection The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Daunorubicin. |
Paclitaxel (with albumin) Injection | Paclitaxel (with albumin) Injection The metabolism of Paclitaxel can be decreased when combined with Daunorubicin. |
Prucalopride | Prucalopride The metabolism of Prucalopride can be decreased when combined with Daunorubicin. |
Ravulizumab-cwvz Injection | Ravulizumab-cwvz Injection The risk or severity of adverse effects can be increased when Daunorubicin is combined with Ravulizumab. |
Emapalumab-lzsg Injection | Emapalumab-lzsg Injection The risk or severity of adverse effects can be increased when Daunorubicin is combined with Emapalumab. |
Siponimod | Siponimod The metabolism of Siponimod can be decreased when combined with Daunorubicin. |
Caplacizumab-yhdp Injection | Caplacizumab-yhdp Injection The risk or severity of bleeding can be increased when Caplacizumab is combined with Daunorubicin. |
Erdafitinib | Erdafitinib The metabolism of Erdafitinib can be decreased when combined with Daunorubicin. |
Risankizumab-rzaa Injection | Risankizumab-rzaa Injection The risk or severity of adverse effects can be increased when Daunorubicin is combined with Risankizumab. |
Alpelisib | Alpelisib The metabolism of Alpelisib can be decreased when combined with Daunorubicin. |
Cladribine | Cladribine The risk or severity of adverse effects can be increased when Cladribine is combined with Daunorubicin. |
Darolutamide | Darolutamide Darolutamide may decrease the excretion rate of Daunorubicin which could result in a higher serum level. |
Entrectinib | Entrectinib The metabolism of Entrectinib can be decreased when combined with Daunorubicin. |
Pexidartinib | Pexidartinib The metabolism of Pexidartinib can be decreased when combined with Daunorubicin. |
Istradefylline | Istradefylline The metabolism of Istradefylline can be increased when combined with Daunorubicin. |
Fedratinib | Fedratinib Fedratinib may decrease the excretion rate of Daunorubicin which could result in a higher serum level. |
Lefamulin | Lefamulin The metabolism of Lefamulin can be decreased when combined with Daunorubicin. |
Phenytoin Injection | Phenytoin Injection The metabolism of Phenytoin can be increased when combined with Daunorubicin. |
Fosphenytoin Injection | Fosphenytoin Injection The metabolism of Fosphenytoin can be decreased when combined with Daunorubicin. |
Zanubrutinib | Zanubrutinib The metabolism of Zanubrutinib can be decreased when combined with Daunorubicin. |
Voxelotor | Voxelotor The serum concentration of Voxelotor can be increased when it is combined with Daunorubicin. |
Lasmiditan | Lasmiditan The serum concentration of Daunorubicin can be increased when it is combined with Lasmiditan. |
Tazemetostat | Tazemetostat The metabolism of Tazemetostat can be decreased when combined with Daunorubicin. |
Cenobamate | Cenobamate The metabolism of Cenobamate can be increased when combined with Daunorubicin. |
Ozanimod | Ozanimod The risk or severity of adverse effects can be increased when Daunorubicin is combined with Ozanimod. |
Selumetinib | Selumetinib The metabolism of Selumetinib can be increased when combined with Daunorubicin. |
Rimegepant | Rimegepant The metabolism of Rimegepant can be increased when combined with Daunorubicin. |
Ripretinib | Ripretinib Ripretinib may decrease the excretion rate of Daunorubicin which could result in a higher serum level. |
Selpercatinib | Selpercatinib The serum concentration of Selpercatinib can be decreased when it is combined with Daunorubicin. |
Capmatinib | Capmatinib The serum concentration of Capmatinib can be decreased when it is combined with Daunorubicin. |
Lemborexant | Lemborexant The serum concentration of Lemborexant can be decreased when it is combined with Daunorubicin. |
Fostemsavir | Fostemsavir Fostemsavir may decrease the excretion rate of Daunorubicin which could result in a higher serum level. |
Belantamab Mafodotin-blmf Injection | Belantamab Mafodotin-blmf Injection Daunorubicin may decrease the excretion rate of Belantamab mafodotin which could result in a higher serum level. |
Pralsetinib | Pralsetinib Pralsetinib may decrease the excretion rate of Daunorubicin which could result in a higher serum level. |
Margetuximab-cmkb Injection | Margetuximab-cmkb Injection The risk or severity of cardiotoxicity can be increased when Margetuximab is combined with Daunorubicin. |
Progestin-Only (drospirenone) Oral Contraceptives | Progestin-Only (drospirenone) Oral Contraceptives The metabolism of Drospirenone can be decreased when combined with Daunorubicin. |
Theophylline | Theophylline The metabolism of Theophylline can be decreased when combined with Daunorubicin. |
Indomethacin | Indomethacin The risk or severity of adverse effects can be increased when Indomethacin is combined with Daunorubicin. |
Naproxen | Naproxen Daunorubicin may decrease the excretion rate of Naproxen which could result in a higher serum level. |
Trazodone | Trazodone The metabolism of Trazodone can be increased when combined with Daunorubicin. |
Hydroxyurea | Hydroxyurea The risk or severity of adverse effects can be increased when Daunorubicin is combined with Hydroxyurea. |
Floxuridine | Floxuridine The risk or severity of adverse effects can be increased when Floxuridine is combined with Daunorubicin. |
Phenobarbital | Phenobarbital Phenobarbital may increase the excretion rate of Daunorubicin which could result in a lower serum level and potentially a reduction in efficacy. |
Methotrexate Injection | Methotrexate Injection The metabolism of Daunorubicin can be decreased when combined with Methotrexate. |
Chlorpromazine | Chlorpromazine Daunorubicin may decrease the excretion rate of Chlorpromazine which could result in a higher serum level. |
Diazepam | Diazepam The metabolism of Diazepam can be increased when combined with Daunorubicin. |
Lorazepam | Lorazepam The metabolism of Lorazepam can be decreased when combined with Daunorubicin. |
Carmustine | Carmustine The risk or severity of adverse effects can be increased when Carmustine is combined with Daunorubicin. |
Procarbazine | Procarbazine The risk or severity of adverse effects can be increased when Daunorubicin is combined with Procarbazine. |
Thioguanine | Thioguanine The risk or severity of adverse effects can be increased when Tioguanine is combined with Daunorubicin. |
Prochlorperazine | Prochlorperazine The metabolism of Prochlorperazine can be decreased when combined with Daunorubicin. |
Bleomycin | Bleomycin The risk or severity of adverse effects can be increased when Bleomycin is combined with Daunorubicin. |
Dapsone | Dapsone The metabolism of Dapsone can be increased when combined with Daunorubicin. |
Oxycodone | Oxycodone The metabolism of Oxycodone can be increased when combined with Daunorubicin. |
Methadone | Methadone The metabolism of Methadone can be increased when combined with Daunorubicin. |
Oxybutynin | Oxybutynin The metabolism of Oxybutynin can be increased when combined with Daunorubicin. |
Azathioprine | Azathioprine The risk or severity of adverse effects can be increased when Daunorubicin is combined with Azathioprine. |
Phentermine | Phentermine The metabolism of Phentermine can be decreased when combined with Daunorubicin. |
Sulfasalazine | Sulfasalazine The risk or severity of adverse effects can be increased when Daunorubicin is combined with Sulfasalazine. |
Hydrocortisone | Hydrocortisone The metabolism of Hydrocortisone can be increased when combined with Daunorubicin. |
Lomustine | Lomustine The risk or severity of adverse effects can be increased when Daunorubicin is combined with Lomustine. |
Doxorubicin | Doxorubicin The metabolism of Doxorubicin can be decreased when combined with Daunorubicin. |
Mechlorethamine | Mechlorethamine The risk or severity of adverse effects can be increased when Daunorubicin is combined with Mechlorethamine. |
Dactinomycin | Dactinomycin The risk or severity of adverse effects can be increased when Daunorubicin is combined with Dactinomycin. |
Carbamazepine | Carbamazepine The metabolism of Carbamazepine can be decreased when combined with Daunorubicin. |
Clonidine | Clonidine The metabolism of Clonidine can be decreased when combined with Daunorubicin. |
Cimetidine | Cimetidine Cimetidine may decrease the excretion rate of Daunorubicin which could result in a higher serum level. |
Warfarin | Warfarin The serum concentration of Warfarin can be increased when it is combined with Daunorubicin. |
Nitrofurantoin | Nitrofurantoin Daunorubicin may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level. |
Digoxin | Digoxin Digoxin may decrease the excretion rate of Daunorubicin which could result in a higher serum level. |
Chloroquine | Chloroquine The metabolism of Chloroquine can be increased when combined with Daunorubicin. |
Quinine | Quinine The metabolism of Quinine can be increased when combined with Daunorubicin. |
Sulfinpyrazone | Sulfinpyrazone Sulfinpyrazone may decrease the excretion rate of Daunorubicin which could result in a higher serum level. |
Chlorothiazide | Chlorothiazide The risk or severity of neutropenia and thrombocytopenia can be increased when Chlorothiazide is combined with Daunorubicin. |
Clindamycin Injection | Clindamycin Injection The metabolism of Clindamycin can be increased when combined with Daunorubicin. |
Amitriptyline | Amitriptyline The metabolism of Amitriptyline can be increased when combined with Daunorubicin. |
Quinidine | Quinidine The metabolism of Quinidine can be decreased when combined with Daunorubicin. |
Rifampin | Rifampin Rifampicin may decrease the excretion rate of Daunorubicin which could result in a higher serum level. |
Tamoxifen | Tamoxifen The metabolism of Daunorubicin can be decreased when combined with Tamoxifen. |
Mitomycin | Mitomycin The risk or severity of adverse effects can be increased when Mitomycin is combined with Daunorubicin. |
Methimazole | Methimazole The risk or severity of adverse effects can be increased when Daunorubicin is combined with Methimazole. |
Propylthiouracil | Propylthiouracil The risk or severity of adverse effects can be increased when Propylthiouracil is combined with Daunorubicin. |
Dextromethorphan | Dextromethorphan The metabolism of Dextromethorphan can be increased when combined with Daunorubicin. |
Chlorpheniramine | Chlorpheniramine The metabolism of Chlorpheniramine can be increased when combined with Daunorubicin. |
Methyclothiazide | Methyclothiazide The risk or severity of neutropenia and thrombocytopenia can be increased when Methyclothiazide is combined with Daunorubicin. |
Hydrochlorothiazide | Hydrochlorothiazide The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Daunorubicin. |
Disulfiram | Disulfiram Daunorubicin may decrease the excretion rate of Disulfiram which could result in a higher serum level. |
Propranolol (Cardiovascular) | Propranolol (Cardiovascular) The metabolism of Propranolol can be increased when combined with Daunorubicin. |
Nortriptyline | Nortriptyline The metabolism of Nortriptyline can be decreased when combined with Daunorubicin. |
Spironolactone | Spironolactone Spironolactone may decrease the excretion rate of Daunorubicin which could result in a higher serum level. |
Mercaptopurine | Mercaptopurine The risk or severity of adverse effects can be increased when Daunorubicin is combined with Mercaptopurine. |
Allopurinol | Allopurinol The risk or severity of adverse effects can be increased when Allopurinol is combined with Daunorubicin. |
Fluorouracil Injection | Fluorouracil Injection The risk or severity of adverse effects can be increased when Fluorouracil is combined with Daunorubicin. |
Colchicine | Colchicine The metabolism of Colchicine can be decreased when combined with Daunorubicin. |
Cefaclor | Cefaclor Daunorubicin may decrease the excretion rate of Cefaclor which could result in a higher serum level. |
Cephalexin | Cephalexin The metabolism of Cephalexin can be decreased when combined with Daunorubicin. |
Dacarbazine | Dacarbazine The risk or severity of adverse effects can be increased when Daunorubicin is combined with Dacarbazine. |
Bacillus Calmette-Guerin (BCG) Vaccine | Bacillus Calmette-Guerin (BCG) Vaccine The risk or severity of infection can be increased when Bacillus calmette-guerin substrain tice live antigen is combined with Daunorubicin. |
Ketoconazole | Ketoconazole Ketoconazole may decrease the excretion rate of Daunorubicin which could result in a higher serum level. |
Thiotepa Injection | Thiotepa Injection The metabolism of Thiotepa can be decreased when combined with Daunorubicin. |
Vincristine Injection | Vincristine Injection The metabolism of Vincristine can be decreased when combined with Daunorubicin. |
Dipyridamole | Dipyridamole Daunorubicin may decrease the excretion rate of Dipyridamole which could result in a higher serum level. |
Vinblastine | Vinblastine The metabolism of Daunorubicin can be decreased when combined with Vinblastine. |
Metoprolol | Metoprolol The metabolism of Metoprolol can be decreased when combined with Daunorubicin. |
Hydroxyzine | Hydroxyzine The metabolism of Hydroxyzine can be increased when combined with Daunorubicin. |
Aspirin | Aspirin The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Daunorubicin. |
Chlorambucil | Chlorambucil The risk or severity of adverse effects can be increased when Chlorambucil is combined with Daunorubicin. |
Alprazolam | Alprazolam The metabolism of Alprazolam can be decreased when combined with Daunorubicin. |
Triazolam | Triazolam The metabolism of Triazolam can be increased when combined with Daunorubicin. |
Diltiazem | Diltiazem The metabolism of Diltiazem can be increased when combined with Daunorubicin. |
Nifedipine | Nifedipine Nifedipine may decrease the excretion rate of Daunorubicin which could result in a higher serum level. |
Verapamil | Verapamil The metabolism of Verapamil can be increased when combined with Daunorubicin. |
Atenolol | Atenolol Atenolol may decrease the excretion rate of Daunorubicin which could result in a higher serum level. |
Cisplatin Injection | Cisplatin Injection The risk or severity of adverse effects can be increased when Cisplatin is combined with Daunorubicin. |
Streptozocin | Streptozocin The risk or severity of adverse effects can be increased when Streptozocin is combined with Daunorubicin. |
Etoposide | Etoposide The metabolism of Etoposide can be decreased when combined with Daunorubicin. |
Glyburide | Glyburide Glyburide may decrease the excretion rate of Daunorubicin which could result in a higher serum level. |
Glipizide | Glipizide Daunorubicin may decrease the excretion rate of Glipizide which could result in a higher serum level. |
Pentoxifylline | Pentoxifylline The risk or severity of bleeding can be increased when Pentoxifylline is combined with Daunorubicin. |
Pentamidine Injection | Pentamidine Injection The metabolism of Pentamidine can be increased when combined with Daunorubicin. |
Pimozide | Pimozide The metabolism of Pimozide can be decreased when combined with Daunorubicin. |
Amiodarone | Amiodarone The metabolism of Amiodarone can be decreased when combined with Daunorubicin. |
Buspirone | Buspirone The metabolism of Buspirone can be increased when combined with Daunorubicin. |
Lovastatin | Lovastatin The metabolism of Lovastatin can be decreased when combined with Daunorubicin. |
Diclofenac | Diclofenac Diclofenac may decrease the excretion rate of Daunorubicin which could result in a higher serum level. |
Interferon Alfa-2b Injection | Interferon Alfa-2b Injection The risk or severity of adverse effects can be increased when Interferon alfa-2b is combined with Daunorubicin. |
Clozapine | Clozapine The risk or severity of neutropenia can be increased when Daunorubicin is combined with Clozapine. |
Idarubicin | Idarubicin The risk or severity of adverse effects can be increased when Daunorubicin is combined with Idarubicin. |
Ofloxacin | Ofloxacin Daunorubicin may decrease the excretion rate of Ofloxacin which could result in a higher serum level. |
Fludarabine Injection | Fludarabine Injection The risk or severity of adverse effects can be increased when Daunorubicin is combined with Fludarabine. |
Pentostatin Injection | Pentostatin Injection The risk or severity of adverse effects can be increased when Pentostatin is combined with Daunorubicin. |
Clarithromycin | Clarithromycin Daunorubicin may decrease the excretion rate of Clarithromycin which could result in a higher serum level. |
Felodipine | Felodipine Daunorubicin may decrease the excretion rate of Felodipine which could result in a higher serum level. |
Pravastatin | Pravastatin Pravastatin may decrease the excretion rate of Daunorubicin which could result in a higher serum level. |
Simvastatin | Simvastatin Daunorubicin may decrease the excretion rate of Simvastatin which could result in a higher serum level. |
Epoetin Alfa, Injection | Epoetin Alfa, Injection The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Daunorubicin. |
Teniposide Injection | Teniposide Injection The metabolism of Daunorubicin can be decreased when combined with Teniposide. |
Doxazosin | Doxazosin The metabolism of Doxazosin can be decreased when combined with Daunorubicin. |
Isradipine | Isradipine Isradipine may decrease the excretion rate of Daunorubicin which could result in a higher serum level. |
Omeprazole | Omeprazole Omeprazole may decrease the excretion rate of Daunorubicin which could result in a higher serum level. |
Cisapride | Cisapride The metabolism of Cisapride can be decreased when combined with Daunorubicin. |
Fluvastatin | Fluvastatin The metabolism of Fluvastatin can be increased when combined with Daunorubicin. |
Venlafaxine | Venlafaxine Venlafaxine may increase the excretion rate of Daunorubicin which could result in a lower serum level and potentially a reduction in efficacy. |
Famciclovir | Famciclovir The metabolism of Famciclovir can be decreased when combined with Daunorubicin. |
Fluvoxamine | Fluvoxamine Fluvoxamine may decrease the excretion rate of Daunorubicin which could result in a higher serum level. |
Nefazodone | Nefazodone Daunorubicin may decrease the excretion rate of Nefazodone which could result in a higher serum level. |
Losartan | Losartan Losartan may decrease the excretion rate of Daunorubicin which could result in a higher serum level. |
Tramadol | Tramadol The metabolism of Tramadol can be decreased when combined with Daunorubicin. |
Vinorelbine Injection | Vinorelbine Injection The metabolism of Daunorubicin can be decreased when combined with Vinorelbine. |
Carboplatin Injection | Carboplatin Injection The risk or severity of adverse effects can be increased when Daunorubicin is combined with Carboplatin. |
Lansoprazole | Lansoprazole Lansoprazole may decrease the excretion rate of Daunorubicin which could result in a higher serum level. |
Ifosfamide Injection | Ifosfamide Injection The metabolism of Ifosfamide can be decreased when combined with Daunorubicin. |
Pegaspargase Injection | Pegaspargase Injection The risk or severity of adverse effects can be increased when Pegaspargase is combined with Daunorubicin. |
Nicardipine | Nicardipine Nicardipine may decrease the excretion rate of Daunorubicin which could result in a higher serum level. |
Ticlopidine | Ticlopidine The metabolism of Daunorubicin can be decreased when combined with Ticlopidine. |
Saquinavir | Saquinavir Saquinavir may decrease the excretion rate of Daunorubicin which could result in a higher serum level. |
Dalteparin Injection | Dalteparin Injection The risk or severity of bleeding can be increased when Dalteparin is combined with Daunorubicin. |
Nisoldipine | Nisoldipine The metabolism of Nisoldipine can be increased when combined with Daunorubicin. |
Glimepiride | Glimepiride Glimepiride may decrease the excretion rate of Daunorubicin which could result in a higher serum level. |
Anastrozole | Anastrozole The risk or severity of cardiotoxicity can be increased when Daunorubicin is combined with Anastrozole. |
Gemcitabine Injection | Gemcitabine Injection The risk or severity of adverse effects can be increased when Gemcitabine is combined with Daunorubicin. |
Indinavir | Indinavir Daunorubicin may decrease the excretion rate of Indinavir which could result in a higher serum level. |
Ritonavir | Ritonavir Ritonavir may decrease the excretion rate of Daunorubicin which could result in a higher serum level. |
Docetaxel Injection | Docetaxel Injection The metabolism of Docetaxel can be decreased when combined with Daunorubicin. |
Clomipramine | Clomipramine The metabolism of Clomipramine can be decreased when combined with Daunorubicin. |
Zafirlukast | Zafirlukast The metabolism of Zafirlukast can be decreased when combined with Daunorubicin. |
Nelfinavir | Nelfinavir Nelfinavir may decrease the excretion rate of Daunorubicin which could result in a higher serum level. |
Azithromycin | Azithromycin The metabolism of Azithromycin can be decreased when combined with Daunorubicin. |
Loratadine | Loratadine Loratadine may decrease the excretion rate of Daunorubicin which could result in a higher serum level. |
Flutamide | Flutamide The metabolism of Flutamide can be increased when combined with Daunorubicin. |
Bicalutamide | Bicalutamide The metabolism of Bicalutamide can be decreased when combined with Daunorubicin. |
Finasteride | Finasteride The metabolism of Finasteride can be increased when combined with Daunorubicin. |
Quetiapine | Quetiapine The metabolism of Quetiapine can be increased when combined with Daunorubicin. |
Capecitabine | Capecitabine The risk or severity of adverse effects can be increased when Daunorubicin is combined with Capecitabine. |
Efavirenz | Efavirenz Efavirenz may decrease the excretion rate of Daunorubicin which could result in a higher serum level. |
Sildenafil | Sildenafil The metabolism of Sildenafil can be increased when combined with Daunorubicin. |
Trastuzumab Injection | Trastuzumab Injection The risk or severity of cardiotoxicity can be increased when Trastuzumab is combined with Daunorubicin. |
Celecoxib | Celecoxib Celecoxib may decrease the excretion rate of Daunorubicin which could result in a higher serum level. |
Rosiglitazone | Rosiglitazone Rosiglitazone may decrease the excretion rate of Daunorubicin which could result in a higher serum level. |
Thalidomide | Thalidomide The risk or severity of adverse effects can be increased when Daunorubicin is combined with Thalidomide. |
Nateglinide | Nateglinide The metabolism of Nateglinide can be increased when combined with Daunorubicin. |
Rabeprazole | Rabeprazole Rabeprazole may decrease the excretion rate of Daunorubicin which could result in a higher serum level. |
Content provided by: AHFS® Patient Medication Information™. © Copyright, 2021. The American Society of Health-System Pharmacists